HER2 and proliferation of wound-induced breast carcinoma.
Mannello
Ferdinando
F
Papa
Stefano
S
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001943:Breast Neoplasms / Q000235:genetics* / Q000556:secondary / Q000601:surgery; D002278:Carcinoma in Situ / Q000601:surgery; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics / Q000502:physiology; D018734:Genes, erbB-2 / Q000235:genetics* / Q000502:physiology; D006801:Humans; D009389:Neovascularization, Pathologic / Q000209:etiology; D000068878:Trastuzumab; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068878:Trastuzumab